Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
Ning‐Ning Liu, Chengxiang Yi, Luqi Wei, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1927-1944.e9
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment
Zahraa Rahal, Yuejiang Liu, Fuduan Peng, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 12, pp. 1736-1752
Closed Access | Times Cited: 5
Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment
Jian Li, Jialu Wu, Yanni Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
MDSCs in bone metastasis: Mechanisms and therapeutic potential
Zhi Li, Qi Xia, Yujie He, et al.
Cancer Letters (2024) Vol. 592, pp. 216906-216906
Closed Access | Times Cited: 4
Fungal influence: The role of the gut mycobiome in women’s health
Tianyi Zhang, Ningning Liu
Cell Host & Microbe (2025) Vol. 33, Iss. 1, pp. 17-19
Closed Access
Exploring Microbial Signatures in Endometrial Tissues with Endometriosis
Weina Guo, Ziying Xu, Sijian Hu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114072-114072
Closed Access
The Role of the Microbiome in Cancer Therapies
Julia Chalif, Naomi E. Goldstein, Yogita Mehra, et al.
Hematology/Oncology Clinics of North America (2025)
Closed Access
Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy
Jing Feng, Yanhong Liu, Liming Gong, et al.
Chinese Chemical Letters (2025), pp. 110907-110907
Closed Access
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy
Tianhang Li, Xiangyu Wu, Xiangyang Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189287-189287
Closed Access
Lung commensal bacteria promote lung cancer progression through NK cell-mediated immunosuppressive microenvironment
Haiyang Wang, Jiayi Hu, Yuchen Ma, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1039-1051
Open Access
Decoding the Tumor-Associated Microbiota: From Origins to Nanomedicine Applications in Cancer Therapy
Ruiqi Wang, Weizheng Li, Hongqian Cao, et al.
Biology (2025) Vol. 14, Iss. 3, pp. 243-243
Open Access
Ginseng polysaccharides ameliorate colorectal tumorigenesis through Lachnospiraceae-mediated immune modulation
Gangfan Zong, Rui Deng, Yehua Pan, et al.
International Journal of Biological Macromolecules (2025), pp. 142015-142015
Closed Access
Mycobiome: an underexplored kingdom in cancer
Sun Yanyan, Ning‐Ning Liu
Microbiology and Molecular Biology Reviews (2025)
Closed Access
Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma
Weiming Mou, Zhe Deng, Lingxuan Zhu, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access
Dapagliflozin ameliorates kidney injury following limb ischemia-reperfusion via the AMPK/SIRT1/NLRP3 pathway
Qiuxiao Zhu, Huiyao Hao, Ya Gao, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Regulating Intratumoral Fungi With Hydrogels: A Novel Approach to Modulating the Tumor Microbiome for Cancer Therapy
Ping Chen, Weiwei Tian, Anqi Zeng, et al.
Cancer Medicine (2025) Vol. 14, Iss. 9
Open Access
“Nutrient–fungi–host” tripartite interaction in cancer progression
Di Wu, Yun‐Xuan Guan, Chen‐Hao Li, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 3
The value of intratumoral microbiota in the diagnosis and prognosis of tumors
Lujia Zhou, Wenjie Zhang, Shiying Fan, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 3
Microbiota alert: Proteobacteria consume arginine to dampen omental antitumor immunity
Xian Du, Zuliang Jie, Qiang Zou
Cell Host & Microbe (2024) Vol. 32, Iss. 7, pp. 1045-1047
Closed Access | Times Cited: 3
Lung microbiota: implications and interactions in chronic pulmonary diseases
Jing Zhou, Wang Hou, Huilin Zhong, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Host–microbiota interaction during cancer progression from bulk to single‐cell level
Yongjing Ma, Run‐Ze Zhu, Ning‐Ning Liu
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Impact of the Lung Microbiota on Development and Progression of Lung Cancer
Amine Belaïd, Barnabé Roméo, Guylène Rignol, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3342-3342
Open Access | Times Cited: 2
Ellagic acid-protein nano-complex inhibits tumor growth by reducing the intratumor bacteria and inhibiting histamine production
Wu Bingbing, Chenlu Yao, Heng Wang, et al.
Biomaterials (2024) Vol. 317, pp. 123078-123078
Closed Access | Times Cited: 2
Untangling the web of intratumor microbiota in lung cancer
Weici Liu, Jingtong Xu, Zheshun Pi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189025-189025
Open Access | Times Cited: 6
Beyond bacteria: How the intratumor mycobiome modulates lung adenocarcinoma progression
Zahraa Rahal, Humam Kadara
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1846-1848
Open Access | Times Cited: 5
Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC
Tao Liu, Ya Guo, Yanxia Liao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5

Scroll to top